Irritable bowel syndrome (IBS) diagnostics market was valued at US$ 2,470.61 million in 2020 and is projected to reach US$ 3,880.91 million by 2028; it is expected to grow at a CAGR of 5.9% from 2021 to 2028.
Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.
Irritable bowel syndrome (IBS) diagnostics market is segmented on the basis of diagnosis, indication, and geography. By geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the irritable bowel syndrome (IBS) diagnostics market, emphasizing on parameters such as market trends, technological advancements, and market dynamics along with the analysis of competitive landscape of world’s leading market players.
Irritable Bowel Syndrome (IBS) Diagnostics Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Irritable bowel syndrome is a chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping.People across the world are witnessing considerable incidence of irritable bowel syndrome. According to the data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients, about 40% of people have mild IBS, around 35% have moderate IBS, and an estimated 25% have severe IBS. Food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. According to a study published on NCBI in 2018, irritable bowel syndrome is estimated to affect around 10–16% of the US population each year. Further, as per the IBS Global Impact Report, in 2016, an estimated mean prevalence of individual countries ranged from 1.1% in France and Iran to 35.5% in Mexico. Latin America had a prevalence rate of 17.5%, Asia 9.6%, North America/Europe/Australia/New Zealand 7.1%, and the Middle East & Africa had a prevalence rate of 5.8%. Such staggering prevalence of irritable bowel syndrome is likely to boost the irritable bowel syndrome (IBS) diagnostics market during the forecast period.
To cope up against irritable bowel syndrome, the market players are taking constructive steps to create programs to spread awareness among the population. For instance, in 2018, the collaboration of Allergan PLC and Ironwood launched an Interactive Digital Destination platform to encourage sufferers to get educated and act. Similarly, in January 2018, Commonwealth Diagnostics International, Inc. collaborated with American professional golfer, Rob Oppenheim to raise awareness about irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO).
Increasing Number of FDA Approvals and Diagnostics Developments Contribute Significantly to Market Growth
Increasing number of FDA approvals and diagnostics development activities are likely to accelerate the growth of the irritable bowel syndrome (IBS) diagnostics market during the forecast period. Majority of the established as well as new players are coming forward to develop and manufacture diagnostic solutions for the disease, which will lead to ample availability of the diagnostic solutions in the market. For instance, in February 2020, Commonwealth Diagnostics International (CDI), Inc. re-launched the IBSchek, the first clinically validated biomarker blood test for mixed-type irritable bowel syndrome (IBS-D, IBS-M) and diarrhea-predominant in a new at-home capillary collection kit. Further, in October 2018, Gemelli Biotech launched the IBS-smart, an innovation in blood testing for irritable bowel syndrome (IBS), in partnership with Medically Associated Science and Technology Program (MAST) at Cedars-Sinai.
The irritable bowel syndrome (IBS) diagnostics market is projected to witness approvals of diagnostic solutions, which will eventually have a positive impact on the growth of the market. For instance, in June 2019, BÜHLMANN Laboratories AG received United States Food and Drug Administration (FDA) 510(k) clearance for its BÜHLMANN fCAL turbo Automated Calprotectin Test and BÜHLMANN fCAL ELISA Calprotectin Test. According to company estimates, the test is anticipated to observe thriving sales in the global market.
Diagnosis Insights
Based on diagnosis, the global irritable bowel syndrome (IBS) diagnostics market is segmented into laboratory tests and imaging tests. In 2020, the laboratory tests segment held the largest share in the market. Moreover, the segment is expected to hold the largest market share by 2028. The market growth is mainly attributed to the growing prevalence of irritable bowel syndrome (IBS) worldwide, which is likely to continue in the coming years due to disturbances in bowel habits and abdominal pain. This, in turn, is boosting the demand for diagnosis of these diseases worldwide.
Indication Insights
Based on indication, the global irritable bowel syndrome (IBS) diagnostics market is segmented into pain and cramping, diarrhea, constipation, and alternating constipation and diarrhea. The pain and cramping segment held the largest market share in 2020, and it is further expected to dominate the market by 2028. Antispasmodics and antidepressants are medication used to treat IBS pain and cramping.
Irritable Bowel Syndrome (IBS) Diagnostics Market, by Treatment – 2020 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Irritable Bowel Syndrome (IBS) Diagnostics Market: Strategic Insights
Market Size Value in US$ 2,470.61 Million in 2020 Market Size Value by US$ 3,880.91 Million by 2028 Growth rate CAGR of 5.9% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Irritable Bowel Syndrome (IBS) Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 2,470.61 Million in 2020 |
| Market Size Value by | US$ 3,880.91 Million by 2028 |
| Growth rate | CAGR of 5.9% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches, and mergers and acquisitions are highly adopted strategies in the global irritable bowel syndrome (IBS) diagnostics market. A few of the recent key product developments are listed below:
In February 2020, Commonwealth Diagnostics International (CDI), Inc., announced the commercial re-launch of IBSchek, the first clinically validated biomarker blood test for diarrhea-predominant and mixed-type irritable bowel syndrome (IBS-D, IBS-M) in a new at-home capillary collection kit.
In January 2019, Gemelli Biotech announced a partnership with Kuwait-based Advanced Medical German Co. (AMG), one of the leading international distributors of medical products and services in the Middle East. Through the partnership, AMG will distribute Gemelli's proprietary diagnostic blood test for IBS, ibs-smart, in major territories in the Middle East and North Africa, including Kuwait, the UAE, Qatar, Saudi Arabia, Egypt, and Turkey.
The COVID-19 pandemic is estimated to have a significant positive impact on the irritable bowel syndrome (IBS) diagnostics market. Majority of the pharmaceutical companies across the world are engaged in the development of vaccines for COVID-19. Moreover, irritable bowel syndrome (IBS) is frequently triggered by COVID-19 stress. Thus, home testing kits are preferable to laboratory testing as laboratory services may be overwhelmed in the pandemic, which is anticipated to have a positive impact on the other segments of the market in the coming months. However, disruptions in the supply chain caused due to the halt in global operations are hindering the market growth.
Irritable Bowel Syndrome (IBS) Diagnostics – Market Segmentation
By Diagnosis
- Laboratory Tests
- Lactose Intolerance Tests
- Breath Test for Bacterial Overgrowth
- Stool Tests
- Blood Tests
- Imaging Tests
- CT Scan or X-Ray
- Upper Endoscopy
- Colonoscopy
By Indication
- Pain and Cramping
- Diarrhea
- Constipation
- Alternating Constipation and Diarrhea
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- UK
- Italy
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East & Africa
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Commonwealth Diagnostics International
- Genova Diagnostics
- Gemelli Biotech
- Prometheus Laboratories
- Inova Diagnostics, Inc.
- Biohit Oyj
- Aerodiagnostics, LLC.
- Metabolic Solutions, Inc.
- Sysmex Corporation
- Bühlmann Laboratories AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Diagnosis ; Indication , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Irritable bowel syndrome (IBS) is defined as gastro-intestinal disorder causing discomfort in the stomach, along with wind, diarrhoea and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. Moreover, IBS diagnostics is done through medical history, physical exam and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test and stool test. The tests are done based on the symptoms such as constipation-predominant, diarrhea-predominant or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy and colonoscopy.
The factors that are driving growth of the market are increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics developments are anticipated to drive the growth of the global irritable bowel syndrome (IBS) diag nostics market during the forecast period. However, challenges in diagnosis of IBS are hindering the market growth.
The irritable bowel syndrome (IBS) diagnostics market majorly consists of the players such Commonwealth Diagnostics International, Genova Diagnostics, Gemelli Biotech, Prometheus Laboratories, Inova Diagnostics, Inc., Biohit Oyj, Aerodiagnostics, LLC., Metabolic Solutions, Inc., Sysmex Corporation, BÃœHLMANN Laboratories AG are among others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market – By Diagnosis
1.3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market – By Indication
1.3.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Market– By Geography
2. Irritable Bowel Syndrome (IBS) Diagnostics Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Irritable Bowel Syndrome (IBS) Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 APAC PEST Analysis
4.2.4 MEA PEST Analysis
4.2.5 SCAM PEST Analysis
4.3 Expert Opinion
5. Irritable Bowel Syndrome (IBS) Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
5.1.2 Increasing number of FDA approvals and diagnostics developments
5.2 Market Restraint
5.2.1 Challenges in Diagnosis of IBS
5.3 Market Opportunity
5.3.1 Increasing disposable incomes of the population
5.4 Future Trend
5.4.1 Development of medical devices for the diagnosis of irritable bowel syndrome
5.5 Impact analysis
6. Irritable Bowel Syndrome (IBS) Diagnostics Market– Global Analysis
6.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Forecast and Analysis
6.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis– by Diagnosis
7.1 Overview
7.2 Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
7.3 Laboratory Tests
7.3.1 Overview
7.3.2 Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Lactose Intolerance Tests
7.3.3.1 Overview
7.3.3.2 Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Breath Test for Bacterial Overgrowth
7.3.4.1 Overview
7.3.4.2 Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Stool Tests
7.3.5.1 Overview
7.3.5.2 Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Blood Tests
7.3.6.1 Overview
7.3.6.2 Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
7.4.1 Overview
7.4.2 Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 CT-Scan or X-Ray
7.4.3.1 Overview
7.4.3.2 CT-Scan or X-Ray: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Upper Endoscopy
7.4.4.1 Overview
7.4.4.2 Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Colonoscopy
7.4.5.1 Overview
7.4.5.2 Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – By Indication
8.1 Overview
8.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)
8.3 Pain and Cramping
8.3.1 Overview
8.3.2 Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diarrhea
8.4.1 Overview
8.4.2 Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Constipation
8.5.1 Overview
8.5.2 Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Alternating Constipation and Diarrhea
8.6.1 Overview
8.6.2 Alternating Constipation and Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
9. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis and Forecasts To 2028 – Geographical Analysis
9.1 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market
9.1.1 Overview
9.1.2 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.3 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
9.1.3.1 North America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 North America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.4 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, By Indication – Revenue and Forecast to 2028 (USD Million)
9.1.5 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
9.1.6 US: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.1 US: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.2 US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)
9.1.6.2.1 US: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2 US: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.6.3 US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication– Revenue and Forecast to 2028 (USD Million)
9.1.7 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.1 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.2 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)
9.1.7.2.1 Canada: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 Canada: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
9.1.8 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.1 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.2 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
9.1.8.2.1 Mexico: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 Mexico: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
9.2 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.3 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
9.2.3.1 Europe: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.3.2 Europe: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
9.2.5 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028(%)
9.2.6 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.6.1 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.6.2 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
9.2.6.2.1 Germany: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.6.2.2 Germany: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.6.3 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
9.2.7 France: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.7.1 France: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.7.2 France: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
9.2.7.2.1 France: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.7.2.2 France: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.7.3 France: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
9.2.8 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.8.1 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.8.2 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
9.2.8.2.1 UK: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.8.2.2 UK: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.8.3 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
9.2.9 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.9.1 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.9.2 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
9.2.9.2.1 Italy: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.9.2.2 Italy: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.9.3 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
9.2.10 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.10.1 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.10.2 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
9.2.10.2.1 Spain: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.10.2.2 Spain: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.10.3 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
9.2.11 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.11.1 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.2.11.2 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
9.2.11.2.1 Rest of Europe: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.11.2.2 Rest of Europe: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.11.3 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)0
9.3 Asia Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market1
9.3.1 Overview1
9.3.2 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)2
9.3.3 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)2
9.3.3.1 Asia-Pacific: Laboratory Tests Market, by Type, 2019–2028 (USD Million)3
9.3.3.2 Asia-Pacific: Imaging Tests Market, by Type, 2019–2028 (USD Million)3
9.3.4 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)4
9.3.5 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)4
9.3.6 China: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)5
9.3.6.1 China: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)5
9.3.6.2 China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)6
9.3.6.2.1 China: Laboratory Tests Market, by Type, 2019–2028 (USD Million)6
9.3.6.2.2 China: Imaging Tests Market, by Type, 2019–2028 (USD Million)6
9.3.6.3 China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)7
9.3.7 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)8
9.3.7.1 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)8
9.3.7.2 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)9
9.3.7.2.1 Japan: Laboratory Tests Market, by Type, 2019–2028 (USD Million)9
9.3.7.2.2 Japan: Imaging Tests Market, by Type, 2019–2028 (USD Million)9
9.3.7.3 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)9
9.3.8 India: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)1
9.3.8.1 India: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)1
9.3.8.2 India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)2
9.3.8.2.1 India: Laboratory Tests Market, by Type, 2019–2028 (USD Million)2
9.3.8.2.2 India: Imaging Tests Market, by Type, 2019–2028 (USD Million)2
9.3.8.3 India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)3
9.3.9 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)4
9.3.9.1 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)4
9.3.9.2 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)5
9.3.9.2.1 Australia: Laboratory Tests Market, by Type, 2019–2028 (USD Million)5
9.3.9.2.2 Australia: Imaging Tests Market, by Type, 2019–2028 (USD Million)5
9.3.9.3 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)6
9.3.10 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7
9.3.10.1 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7
9.3.10.2 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)8
9.3.10.2.1 South Korea: Laboratory Tests Market, by Type, 2019–2028 (USD Million)8
9.3.10.2.2 South Korea: Imaging Tests Market, by Type, 2019–2028 (USD Million)9
9.3.10.3 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)9
9.3.11 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0
9.3.11.1 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0
9.3.11.2 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019–2028 (USD Million)1
9.3.11.2.1 Rest of Asia-Pacific: Laboratory Tests Market, by Type, 2019–2028 (USD Million)1
9.3.11.2.2 Rest of Asia-Pacific: Imaging Tests Market, by Type, by Imaging Tests, 2019–2028 (USD Million)2
9.3.11.3 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019–2028 (USD Million)2
9.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market3
9.4.1 Overview3
9.4.2 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)4
9.4.3 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4
9.4.3.1 Middle East and Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5
9.4.3.2 Middle East and Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5
9.4.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)6
9.4.5 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)6
9.4.6 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7
9.4.6.1 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7
9.4.6.2 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)8
9.4.6.2.1 Saudi Arabia: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8
9.4.6.2.2 Saudi Arabia: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8
9.4.6.3 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)9
9.4.7 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0
9.4.7.1 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0
9.4.7.2 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)1
9.4.7.2.1 South Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
9.4.7.2.2 South Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
9.4.7.3 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)2
9.4.8 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3
9.4.8.1 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3
9.4.8.2 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4
9.4.8.2.1 UAE: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)4
9.4.8.2.2 UAE: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5
9.4.8.3 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)5
9.4.9 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6
9.4.9.1 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6
9.4.9.2 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)7
9.4.9.2.1 Rest of Middle East and Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7
9.4.9.2.2 Rest of Middle East and Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7
9.4.9.3 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)8
9.5 South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market9
9.5.1 Overview9
9.5.2 South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0
9.5.3 South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)0
9.5.3.1 South And Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
9.5.3.2 South And Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
9.5.4 South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)2
9.5.5 South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)3
9.5.6 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3
9.5.6.1 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3
9.5.6.2 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4
9.5.6.2.1 Brazil: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)4
9.5.6.2.2 Brazil: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5
9.5.6.3 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)5
9.5.7 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6
9.5.7.1 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6
9.5.7.2 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)7
9.5.7.2.1 Argentina: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7
9.5.7.2.2 Argentina: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8
9.5.7.3 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)8
9.5.8 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)9
9.5.8.1 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)9
9.5.8.2 Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)0
9.5.8.2.1 Rest of South And Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)0
9.5.8.2.2 Rest of South And Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
9.5.8.3 Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
10. Impact of COVID-19 Pandemic on Global Irritable Bowel Syndrome (IBS) Diagnostics Market2
10.1 North America: Impact Assessment of COVID-19 Pandemic2
10.2 Europe: Impact Assessment of COVID-19 Pandemic4
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic6
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic7
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic8
11. Irritable Bowel Syndrome (IBS) Diagnostics Market– Industry Landscape9
11.1 Overview9
11.2 Growth Strategies Done by the Companies in the Market, (%)9
11.3 Organic Developments0
11.3.1 Overview0
11.4 Inorganic Developments1
11.4.1 Overview1
12. Company Profiles2
12.1 Commonwealth Diagnostics International2
12.1.1 Key Facts2
12.1.2 Business Description2
12.1.3 Products and Services2
12.1.4 Financial Overview2
12.1.5 SWOT Analysis3
12.1.6 Key Developments3
12.2 Genova Diagnostics5
12.2.1 Key Facts5
12.2.2 Business Description5
12.2.3 Products and Services5
12.2.4 Financial Overview5
12.2.5 SWOT Analysis6
12.2.6 Key Developments6
12.3 Gemelli Biotech7
12.3.1 Key Facts7
12.3.2 Business Description7
12.3.3 Products and Services7
12.3.4 Financial Overview7
12.3.5 SWOT Analysis8
12.3.6 Key Developments8
12.4 Prometheus Laboratories9
12.4.1 Key Facts9
12.4.2 Business Description9
12.4.3 Products and Services9
12.4.4 Financial Overview9
12.4.5 SWOT Analysis0
12.4.6 Key Developments0
12.5 Inova Diagnostics, Inc.1
12.5.1 Key Facts1
12.5.2 Business Description1
12.5.3 Products and Services1
12.5.4 Financial Overview1
12.5.5 SWOT Analysis2
12.5.6 Key Developments2
12.6 Biohit Oyj3
12.6.1 Key Facts3
12.6.2 Business Description3
12.6.3 Products and Services3
12.6.4 Financial Overview4
12.6.5 SWOT Analysis5
12.6.6 Key Developments5
12.7 Aerodiagnostics, LLC.6
12.7.1 Key Facts6
12.7.2 Business Description6
12.7.3 Products and Services6
12.7.4 Financial Overview6
12.7.5 SWOT Analysis7
12.7.6 Key Developments7
12.8 Metabolic Solutions, Inc.8
12.8.1 Key Facts8
12.8.2 Business Description8
12.8.3 Products and Services8
12.8.4 Financial Overview8
12.8.5 SWOT Analysis9
12.8.6 Key Developments9
12.9 Sysmex Corporation (Sysmex Europe GmbH)9
12.9.1 Key Facts9
12.9.2 Business Description9
12.9.3 Products and Services0
12.9.4 Financial Overview0
12.9.5 SWOT Analysis2
12.9.6 Key Developments2
12.10 BÜHLMANN Laboratories AG3
12.10.1 Key Facts3
12.10.2 Business Description3
12.10.3 Products and Services3
12.10.4 Financial Overview3
12.10.5 SWOT Analysis4
12.10.6 Key Developments4
13. Appendix5
13.1 About the Insight Partners5
13.2 Glossary of Terms5
LIST OF TABLES
Table 1. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, By Indication – Revenue and Forecast to 2028 (USD Million)
Table 5. US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)
Table 6. US: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. US: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication-Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis– Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
Table 18. Europe: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Europe: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
Table 21. Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
Table 22. Germany: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Germany: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 24. Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
Table 25. France: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
Table 26. France: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 27. France: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. France: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
Table 29. UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
Table 30. UK: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 31. UK: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 32. UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
Table 33. Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
Table 34. Italy: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Italy: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
Table 37. Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
Table 38. Spain: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Spain: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 40. Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Europe: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Rest of Europe: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 44. Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)0
Table 45. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)2
Table 46. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)3
Table 47. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)3
Table 48. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)4
Table 49. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)6
Table 50. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)6
Table 51. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)6
Table 52. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)7
Table 53. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)9
Table 54. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)9
Table 55. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)9
Table 56. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)0
Table 57. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)2
Table 58. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)2
Table 59. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)2
Table 60. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)3
Table 61. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)5
Table 62. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)5
Table 63. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)5
Table 64. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)6
Table 65. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)8
Table 66. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)8
Table 67. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)9
Table 68. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)9
Table 69. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)1
Table 70. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)1
Table 71. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests – Revenue and Forecast to 2028 (USD Million)2
Table 72. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication – Revenue and Forecast to 2028 (USD Million)2
Table 73. Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4
Table 74. Middle East and Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5
Table 75. Middle East and Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5
Table 76. Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)6
Table 77. Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)8
Table 78. Saudi Arabia: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8
Table 79. Saudi Arabia: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8
Table 80. Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)9
Table 81. South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)1
Table 82. South Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
Table 83. South Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
Table 84. South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)2
Table 85. UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4
Table 86. UAE: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)4
Table 87. UAE: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5
Table 88. UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)5
Table 89. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)7
Table 90. Rest of Middle East and Africa: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7
Table 91. Rest of Middle East and Africa: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7
Table 92. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)8
Table 93. South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)0
Table 94. South And Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
Table 95. South And Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
Table 96. South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)2
Table 97. Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)4
Table 98. Brazil: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)4
Table 99. Brazil: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)5
Table 100. Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)5
Table 101. Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)7
Table 102. Argentina: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)7
Table 103. Argentina: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)8
Table 104. Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)8
Table 105. Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)0
Table 106. Rest of South And Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)0
Table 107. Rest of South And Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)1
Table 108. Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)1
Table 109. Organic Developments Done By Companies0
Table 110. Inorganic Developments Done By Companies1
Table 111. Glossary of Terms, Irritable Bowel Syndrome (IBS) Diagnostics Market5
LIST OF FIGURES
Figure 1. Irritable Bowel Syndrome (IBS) Diagnostics Market Segmentation
Figure 2. Irritable Bowel Syndrome (IBS) Diagnostics Segmentation, By Region
Figure 3. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Overview
Figure 4. Laboratory Tests Systems Held Largest Share of Diagnosis Segment in Irritable Bowel Syndrome (IBS) Diagnostics Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Irritable Bowel Syndrome (IBS) Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Irritable Bowel Syndrome (IBS) Diagnostics Market– Leading Country Markets (US$ Million)
Figure 8. Global Irritable Bowel Syndrome (IBS) Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. APAC: PEST Analysis
Figure 12. MEA: PEST Analysis
Figure 13. SCAM: PEST Analysis
Figure 14. Irritable Bowel Syndrome (IBS) Diagnostics Market Impact Analysis of Driver and Restraints
Figure 15. Global Irritable Bowel Syndrome (IBS) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Irritable Bowel Syndrome (IBS) Diagnostics Market– By Geography Forecast and Analysis – 2020- 2028
Figure 17. Market Positioning of Key Players in Global Irritable Bowel Syndrome (IBS) Diagnostics Market
Figure 18. Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
Figure 19. Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. CT-Scan or X-Ray: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)
Figure 29. Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Alternating Constipation and Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)
Figure 34. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 35. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 36. US: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)
Figure 40. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 41. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 42. Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. France: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. UK: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)1
Figure 49. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2027 (USD Million)2
Figure 50. Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)4
Figure 51. China: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)5
Figure 52. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)8
Figure 53. India: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)1
Figure 54. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)4
Figure 55. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7
Figure 56. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0
Figure 57. Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)3
Figure 58. Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2027 (USD Million)4
Figure 59. Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)6
Figure 60. Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)7
Figure 61. South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)0
Figure 62. UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)3
Figure 63. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6
Figure 64. South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)9
Figure 65. South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2028 (USD Million)0
Figure 66. South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)3
Figure 67. Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)4
Figure 68. Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)6
Figure 69. Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)9
Figure 70. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in North American Countries3
Figure 71. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in European Countries5
Figure 72. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Asia Pacific Countries6
Figure 73. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Rest of the World7
Figure 74. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Rest of the World8
Figure 75. Growth Strategies Done by the Companies in the Market, (%)
1
The List of Companies - Irritable Bowel Syndrome (IBS) Diagnostics Market
- Commonwealth Diagnostics International
- Genova Diagnostics
- Gemelli Biotech
- Prometheus Laboratories
- Inova Diagnostics, Inc.
- Biohit Oyj
- Aerodiagnostics, LLC.
- Metabolic Solutions, Inc.
- Sysmex Corporation
- BÜHLMANN Laboratories AG.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Irritable Bowel Syndrome (IBS) Diagnostics Market
Mar 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)